ABSTRACT
Background: the hematopoietic system is sensitive to the adverse effects of ionizing radiation. Cellular therapies utilizing mesenchymal stem cells or vascular endothelial cells have been explored as potential countermeasures for radiation hematopoietic injuries. We investigated cells cultured from amnion [Amnion-derived Multipotent Progenitor cells, AMPs] for effects on hematopoietic recovery following total body irradiation in mice
Materials and Methods: C57BL/6J mice were sham-irradiated or exposed to 60Co irradiation [7.75 - 7.90 Gy, 0.6 Gy/min]. Either AMPs [5 × 106 cells/animal] or vehicle were administered 24 h post irradiation via intraperitoneal injection
Results: we observed a 13% and 20% improvement in 30-day survival of mice treated with AMPs compared with treatment with vehicle following irradiation at 7.75 and 7.90 Gy, respectively. AMP treatment was characterized by a trend toward accelerated recovery of white blood cells, neutrophils, reticulocytes, and monocytes, measured through day 40 post irradiation a9er 7.75 Gy. AMP treatment enhanced hematopoietic cell repopulation of spleen and femoral bone marrow as measured by total nucleated cell and hematopoietic progenitor cell counts in comparison to vehicle-treated animals. FACS analysis showed that AMPs treatment significantly mitigated the reduction in CD11b+/Gr-1int and CD11b+/Gr-1high bone marrow cell populations at the nadir, and improved recovery of these cell types
Conclusion: together, our data indicate that AMPs reduced hematopoietic toxicity induced by ionizing radiation when infused within 24 h a9er radiation injury
ABSTRACT
We aimed to compare the duration of survival among subjects receiving brachytherapy (BT) in combination with Nd:YAG laser therapy (LT), and those receiving LT or BT alone. The medical records of subjects who received endobronchial treatment for unresectable tracheobronchial malignancies between January 1997 and December 1999 in a single center were reviewed retrospectively. A total of 80 patients were evaluated. The overall symptomatic response rate after treatment was 86.5%. Median survival durations for the LT, BT, and combined therapy (CT) group were 111, 115, and 264 days, respectively. The survival duration was significantly longer in the CT group than in the BT group (p=0.0078), but the difference was not statistically significant between the CT and the LT group. The bronchoscopic finding of endobronchial polypoid lesion was associated with a longer survival time than extraluminal with compression type (p=0.0023) by univariate analysis. Other factors associated with the better prognosis included hemoglobin > or = 12.5 g/dL, serum albumin level > or =37 g/L, and BT dose > or = 15 Gy at 1 cm distance. Of these factors, specific bronchoscopic findings, serum albumin level, CT modality, and dose of BT retained statistical significance in multivariate analysis. In conclusion, combined LT and BT is associated with increased patient survival compared with BT alone. Combined therapy may improve survival time in selected patients with endobronchial malignancies.
Subject(s)
Aged , Female , Humans , Male , Middle Aged , Brachytherapy , Carcinoma, Non-Small-Cell Lung/mortality , Combined Modality Therapy , Iridium Radioisotopes/therapeutic use , Laser Therapy , Lung Neoplasms/mortality , Prognosis , Retrospective Studies , Survival AnalysisABSTRACT
Ninety seven maxillary sinuses in 50 patients were studied to compare the diagnostic value of sinus [proof puncture] and antroscopy. The findings were categorized for each procedure into normal or diseased sinus with 3 sub types in the diseased category: straw colour fluid, turbid washout and frankpus for sinus washout, and congested mucosa, polypoidal mucosa, and frankpus for antroscopy. Twenty eight and ten sinuses were classified as diseased by antroscopy and sinus washout respectively. Statistical comparison of these results showed that antroscopy is significantly better than sinus washout in diagnosing maxillary sinus disease [P<0.001]